Trial of Endobronchial Ultrasound Guided Fine Needle Aspiration Techniques

NCT ID: NCT01741571

Last Updated: 2020-09-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

32 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-12-31

Study Completion Date

2017-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Endobronchial ultrasound-guided transbronchial fine needle aspiration (EBUS-TBNA) techniques have not been well studied. The investigators will conduct a randomized study comparing the diagnostic yield and specimen quality of EBUS-FNA performed with and without suction applied.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Consecutive patients with suspected malignant peribronchial masses or lymph nodes undergoing endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) will be enrolled. All participants will have 4 needle aspirations of each targeted peribronchial lesion. Two needle aspirations will be performed while applying suction and 2 needle aspirations will be performed without applying suction in random order. The investigators will compare the diagnostic yield and the quality of the specimens obtained using the two techniques.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lung Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SEQUENTIAL

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

EBUS guided FNA with suction

Device/procedure: lymph node tissue collection using fine needle aspiration with suction applied.

Four fine needle aspirations will be taken sequentially from each lymph node. Two with suction and two without suction applied.

Group Type ACTIVE_COMPARATOR

EBUS guided FNA with and without suction

Intervention Type DEVICE

Device/procedure: lymph node tissue collection using needle with and without suction applied.

Four fine needle aspirations will be taken from each lymph node. Two with suction and two without suction applied.

EBUS guided FNA without suction

Device/procedure: lymph node tissue collection using fine needle aspiration without suction applied.

Four fine needle aspirations will be taken sequentially from each lymph node. Two with suction and two without suction applied.

Group Type EXPERIMENTAL

EBUS guided FNA with and without suction

Intervention Type DEVICE

Device/procedure: lymph node tissue collection using needle with and without suction applied.

Four fine needle aspirations will be taken from each lymph node. Two with suction and two without suction applied.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

EBUS guided FNA with and without suction

Device/procedure: lymph node tissue collection using needle with and without suction applied.

Four fine needle aspirations will be taken from each lymph node. Two with suction and two without suction applied.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult undergoing EBUS at AUBMC for suspected malignancy

Exclusion Criteria

* Coagulopathy
* The lesion cannot be sampled because of intervening tumor or blood vessels.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

American University of Beirut Medical Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Hassan Chami

Assistant Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Hassan Chami, MD

Role: PRINCIPAL_INVESTIGATOR

American University of Beirut Medical Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

American University of Beirut

Beirut, , Lebanon

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Lebanon

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

AmericanUBMC

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

EBUS-TBNA vs Flex 19G EBUS-TBNA
NCT02916459 UNKNOWN NA
EBUS-TBNA vs Acquire TBNB
NCT04200105 UNKNOWN NA